ERF_HUMAN - dbPTM
ERF_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID ERF_HUMAN
UniProt AC P50548
Protein Name ETS domain-containing transcription factor ERF
Gene Name ERF
Organism Homo sapiens (Human).
Sequence Length 548
Subcellular Localization Nucleus.
Protein Description Potent transcriptional repressor that binds to the H1 element of the Ets2 promoter. May regulate other genes involved in cellular proliferation. Required for extraembryonic ectoderm differentiation, ectoplacental cone cavity closure, and chorioallantoic attachment (By similarity). May be important for regulating trophoblast stem cell differentiation (By similarity)..
Protein Sequence MKTPADTGFAFPDWAYKPESSPGSRQIQLWHFILELLRKEEYQGVIAWQGDYGEFVIKDPDEVARLWGVRKCKPQMNYDKLSRALRYYYNKRILHKTKGKRFTYKFNFNKLVLVNYPFIDVGLAGGAVPQSAPPVPSGGSHFRFPPSTPSEVLSPTEDPRSPPACSSSSSSLFSAVVARRLGRGSVSDCSDGTSELEEPLGEDPRARPPGPPDLGAFRGPPLARLPHDPGVFRVYPRPRGGPEPLSPFPVSPLAGPGSLLPPQLSPALPMTPTHLAYTPSPTLSPMYPSGGGGPSGSGGGSHFSFSPEDMKRYLQAHTQSVYNYHLSPRAFLHYPGLVVPQPQRPDKCPLPPMAPETPPVPSSASSSSSSSSSPFKFKLQPPPLGRRQRAAGEKAVAGADKSGGSAGGLAEGAGALAPPPPPPQIKVEPISEGESEEVEVTDISDEDEEDGEVFKTPRAPPAPPKPEPGEAPGASQCMPLKLRFKRRWSEDCRLEGGGGPAGGFEDEGEDKKVRGEGPGEAGGPLTPRRVSSDLQHATAQLSLEHRDS
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
2Ubiquitination------MKTPADTGF
------CCCCCCCCC
64.32-
2Methylation------MKTPADTGF
------CCCCCCCCC
64.32-
3Phosphorylation-----MKTPADTGFA
-----CCCCCCCCCC
23.5523401153
7Phosphorylation-MKTPADTGFAFPDW
-CCCCCCCCCCCCCC
35.9823927012
16PhosphorylationFAFPDWAYKPESSPG
CCCCCCCCCCCCCCC
23.8723927012
17UbiquitinationAFPDWAYKPESSPGS
CCCCCCCCCCCCCCH
34.26-
20PhosphorylationDWAYKPESSPGSRQI
CCCCCCCCCCCHHHH
50.8122167270
21PhosphorylationWAYKPESSPGSRQIQ
CCCCCCCCCCHHHHH
31.4522167270
24PhosphorylationKPESSPGSRQIQLWH
CCCCCCCHHHHHHHH
25.1322167270
30UbiquitinationGSRQIQLWHFILELL
CHHHHHHHHHHHHHH
2.83-
71UbiquitinationARLWGVRKCKPQMNY
HHHHCCCCCCCCCCH
44.17-
73UbiquitinationLWGVRKCKPQMNYDK
HHCCCCCCCCCCHHH
41.12-
80UbiquitinationKPQMNYDKLSRALRY
CCCCCHHHHHHHHHH
37.69-
105UbiquitinationKGKRFTYKFNFNKLV
CCCCEEEEECCCEEE
30.6721890473
105UbiquitinationKGKRFTYKFNFNKLV
CCCCEEEEECCCEEE
30.6721890473
131PhosphorylationAGGAVPQSAPPVPSG
CCCCCCCCCCCCCCC
36.3530183078
137PhosphorylationQSAPPVPSGGSHFRF
CCCCCCCCCCCCCCC
56.8929514088
140PhosphorylationPPVPSGGSHFRFPPS
CCCCCCCCCCCCCCC
23.9929514088
147PhosphorylationSHFRFPPSTPSEVLS
CCCCCCCCCHHHCCC
53.8626503892
148PhosphorylationHFRFPPSTPSEVLSP
CCCCCCCCHHHCCCC
36.2930266825
150PhosphorylationRFPPSTPSEVLSPTE
CCCCCCHHHCCCCCC
40.1929255136
154PhosphorylationSTPSEVLSPTEDPRS
CCHHHCCCCCCCCCC
34.6426503892
156PhosphorylationPSEVLSPTEDPRSPP
HHHCCCCCCCCCCCC
50.0429255136
161PhosphorylationSPTEDPRSPPACSSS
CCCCCCCCCCCCCCC
40.3927794612
166PhosphorylationPRSPPACSSSSSSLF
CCCCCCCCCCHHHHH
35.0523663014
167PhosphorylationRSPPACSSSSSSLFS
CCCCCCCCCHHHHHH
33.8423663014
168PhosphorylationSPPACSSSSSSLFSA
CCCCCCCCHHHHHHH
20.2523663014
169PhosphorylationPPACSSSSSSLFSAV
CCCCCCCHHHHHHHH
26.3723663014
170PhosphorylationPACSSSSSSLFSAVV
CCCCCCHHHHHHHHH
32.7723663014
171PhosphorylationACSSSSSSLFSAVVA
CCCCCHHHHHHHHHH
35.0723663014
174PhosphorylationSSSSSLFSAVVARRL
CCHHHHHHHHHHHHH
26.0023663014
183MethylationVVARRLGRGSVSDCS
HHHHHHCCCCCCCCC
38.51-
185PhosphorylationARRLGRGSVSDCSDG
HHHHCCCCCCCCCCC
19.6523401153
187PhosphorylationRLGRGSVSDCSDGTS
HHCCCCCCCCCCCCC
34.3029255136
190PhosphorylationRGSVSDCSDGTSELE
CCCCCCCCCCCCCCC
44.0323927012
193PhosphorylationVSDCSDGTSELEEPL
CCCCCCCCCCCCCCC
24.8223927012
194PhosphorylationSDCSDGTSELEEPLG
CCCCCCCCCCCCCCC
45.7923927012
218MethylationPPDLGAFRGPPLARL
CCCCCCCCCCCCCCC
57.06-
224MethylationFRGPPLARLPHDPGV
CCCCCCCCCCCCCCC
57.33-
233MethylationPHDPGVFRVYPRPRG
CCCCCCEEEECCCCC
25.34-
246PhosphorylationRGGPEPLSPFPVSPL
CCCCCCCCCCCCCCC
34.9022817900
251PhosphorylationPLSPFPVSPLAGPGS
CCCCCCCCCCCCCCC
17.9022817900
313PhosphorylationSPEDMKRYLQAHTQS
CHHHHHHHHHHHHHH
9.5423403867
318PhosphorylationKRYLQAHTQSVYNYH
HHHHHHHHHHHHHHC
26.0928152594
319AcetylationRYLQAHTQSVYNYHL
HHHHHHHHHHHHHCC
22.49-
320PhosphorylationYLQAHTQSVYNYHLS
HHHHHHHHHHHHCCC
27.9428152594
322PhosphorylationQAHTQSVYNYHLSPR
HHHHHHHHHHCCCCC
18.4323403867
324PhosphorylationHTQSVYNYHLSPRAF
HHHHHHHHCCCCCCC
6.1023927012
327PhosphorylationSVYNYHLSPRAFLHY
HHHHHCCCCCCCCCC
10.0623401153
329MethylationYNYHLSPRAFLHYPG
HHHCCCCCCCCCCCC
34.30-
334PhosphorylationSPRAFLHYPGLVVPQ
CCCCCCCCCCCCCCC
10.9227642862
357PhosphorylationLPPMAPETPPVPSSA
CCCCCCCCCCCCCCC
31.6525850435
362PhosphorylationPETPPVPSSASSSSS
CCCCCCCCCCCCCCC
38.4825850435
363PhosphorylationETPPVPSSASSSSSS
CCCCCCCCCCCCCCC
26.5427251275
365PhosphorylationPPVPSSASSSSSSSS
CCCCCCCCCCCCCCC
32.4727251275
366PhosphorylationPVPSSASSSSSSSSS
CCCCCCCCCCCCCCC
33.6827251275
367PhosphorylationVPSSASSSSSSSSSP
CCCCCCCCCCCCCCC
31.5725850435
368PhosphorylationPSSASSSSSSSSSPF
CCCCCCCCCCCCCCC
35.8725850435
369PhosphorylationSSASSSSSSSSSPFK
CCCCCCCCCCCCCCC
35.8725850435
370PhosphorylationSASSSSSSSSSPFKF
CCCCCCCCCCCCCCE
35.8725850435
371PhosphorylationASSSSSSSSSPFKFK
CCCCCCCCCCCCCEE
36.4627251275
372PhosphorylationSSSSSSSSSPFKFKL
CCCCCCCCCCCCEEC
43.9327251275
373PhosphorylationSSSSSSSSPFKFKLQ
CCCCCCCCCCCEECC
35.9825850435
376MethylationSSSSSPFKFKLQPPP
CCCCCCCCEECCCCC
45.00-
378SumoylationSSSPFKFKLQPPPLG
CCCCCCEECCCCCCC
46.96-
378SumoylationSSSPFKFKLQPPPLG
CCCCCCEECCCCCCC
46.96-
394AcetylationRQRAAGEKAVAGADK
HHHHCHHHCCCCCCC
47.4423749302
402PhosphorylationAVAGADKSGGSAGGL
CCCCCCCCCCCCCHH
49.2728555341
405PhosphorylationGADKSGGSAGGLAEG
CCCCCCCCCCHHHCC
27.5428387310
431PhosphorylationQIKVEPISEGESEEV
CCEEEECCCCCCCEE
50.7127422710
435PhosphorylationEPISEGESEEVEVTD
EECCCCCCCEEEEEE
50.3327422710
441PhosphorylationESEEVEVTDISDEDE
CCCEEEEEECCCCCC
17.7025072903
444PhosphorylationEVEVTDISDEDEEDG
EEEEEECCCCCCCCC
37.4425072903
456PhosphorylationEDGEVFKTPRAPPAP
CCCCEECCCCCCCCC
13.4221406692
465SumoylationRAPPAPPKPEPGEAP
CCCCCCCCCCCCCCC
62.04-
465SumoylationRAPPAPPKPEPGEAP
CCCCCCCCCCCCCCC
62.0428112733
475PhosphorylationPGEAPGASQCMPLKL
CCCCCCCCCCCCCEE
29.8128555341
481SumoylationASQCMPLKLRFKRRW
CCCCCCCEECEEECC
31.5728112733
489PhosphorylationLRFKRRWSEDCRLEG
ECEEECCCCCCCCCC
23.0323401153
512SumoylationEDEGEDKKVRGEGPG
CCCCCCCCCCCCCCC
49.8728112733
512SumoylationEDEGEDKKVRGEGPG
CCCCCCCCCCCCCCC
49.87-
526PhosphorylationGEAGGPLTPRRVSSD
CCCCCCCCCCCCCHH
20.2019664994
531PhosphorylationPLTPRRVSSDLQHAT
CCCCCCCCHHHHHHH
19.1429255136
532PhosphorylationLTPRRVSSDLQHATA
CCCCCCCHHHHHHHH
39.2129255136
538PhosphorylationSSDLQHATAQLSLEH
CHHHHHHHHHHHHHC
16.8923927012
542PhosphorylationQHATAQLSLEHRDS-
HHHHHHHHHHCCCC-
21.4523927012
548PhosphorylationLSLEHRDS-------
HHHHCCCC-------
41.9223927012

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources
161SPhosphorylationKinaseMAPK1P28482
GPS
246SPhosphorylationKinaseMAPK1P28482
GPS
251SPhosphorylationKinaseMAPK1P28482
GPS
526TPhosphorylationKinaseMK01P28482
PhosphoELM

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference
526TPhosphorylation

7588608

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of ERF_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
SPOP_HUMANSPOPphysical
26344095
MARF1_HUMANKIAA0430physical
27173435
PAN2_HUMANPAN2physical
27173435
NISCH_HUMANNISCHphysical
27173435

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
600775Craniosynostosis 4 (CRS4)
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of ERF_HUMAN

loading...

Related Literatures of Post-Translational Modification
Phosphorylation
ReferencePubMed
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions.";
Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.;
Sci. Signal. 2:RA46-RA46(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-431; SER-444 ANDTHR-526, AND MASS SPECTROMETRY.
"A quantitative atlas of mitotic phosphorylation.";
Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.;
Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-3; THR-7; TYR-16;SER-20; SER-21; THR-148; SER-171; SER-185; SER-187; SER-190; SER-327;SER-431; SER-435; THR-441; SER-444; THR-526; SER-531 AND SER-548, ANDMASS SPECTROMETRY.
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks.";
Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.;
Cell 127:635-648(2006).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-21; SER-185; SER-187;SER-190 AND SER-531, AND MASS SPECTROMETRY.
"A probability-based approach for high-throughput proteinphosphorylation analysis and site localization.";
Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.;
Nat. Biotechnol. 24:1285-1292(2006).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-526, AND MASSSPECTROMETRY.
"ERF: an ETS domain protein with strong transcriptional repressoractivity, can suppress ets-associated tumorigenesis and is regulatedby phosphorylation during cell cycle and mitogenic stimulation.";
Sgouras D.N., Athanasiou M.A., Beal G.J. Jr., Fisher R.J., Blair D.G.,Mavrothalassitis G.J.;
EMBO J. 14:4781-4793(1995).
Cited for: NUCLEOTIDE SEQUENCE [MRNA], PHOSPHORYLATION AT THR-526, ANDMUTAGENESIS OF THR-526.

TOP